Preço das Ações
785.51
Mudança Diária
18.88 2.46%
Mensal
-3.29%
Anual
10.64%
Q1 Previsão
761.39




Credores Comerciais Alterar Data
AbbVie USD 32.25B 1.2B 2025-06
Agios Pharmaceuticals USD 19.55M 2.02M 2025-09
Alnylam Pharmaceuticals USD 117.59M 15.2M 2025-09
Amgen USD 19.64B 1.61B 2025-09
Astellas Pharma JPY 181.95B 13.3B 2025-12
AstraZeneca USD 25.03B 1.04B 2025-09
Biogen USD 432M 18.9M 2025-12
BioMarin Pharmaceutical USD 798.44M 114.19M 2025-09
Bristol-Myers Squibb USD 4.29B 1.14B 2025-09
Eli Lilly USD 4.26B 186.5M 2025-09
Gilead Sciences USD 808M 226M 2025-09
GlaxoSmithKline GBP 15.38B 294M 2025-12
Incyte USD 171.92M 1.24B 2025-09
Ionis Pharmaceuticals USD 14.33M 8.47M 2025-09
J&J USD 9.62B 161M 2025-09
Kyowa Hakko Kirin JPY 123.72B 14.99B 2025-09
Merck USD 4.15B 102M 2025-09
Moderna USD 267M 92M 2025-09
Neurocrine Biosciences USD 119.9M 15.3M 2025-09
Novartis USD 4.56B 49M 2025-09
Novartis USD 4.56B 49M 2025-09
Pfizer USD 5.02B 142M 2025-09
Regeneron Pharmaceuticals USD 5.83B 4.93B 2025-12
Roche Holding CHF 5.78B 1.27B 2025-12
Sanofi EUR 22.93B 2.89B 2025-12
Sarepta Therapeutics USD 94.02M 42.69M 2025-09
Teva Pharmaceutical Industries USD 2.53B 176M 2025-12
Ultragenyx Pharmaceutical USD 40.57M 6.33M 2025-09
United Therapeutics USD 468M 36M 2025-09
Vertex Pharmaceuticals USD 4.03B 320.8M 2025-09


Regeneron Pharmaceuticals Credores Comerciais - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.